Learn More
Medchemexpress LLC N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]benzamide | 303162-79-0 | MFCD17012805 | 99.8% | 399.51 g/mol | C24H21N3OS | 200 MG

Supplier: Medchemexpress LLC HY10456200MG
TAK-715 is an orally active, potent p38 MAPK inhibitor used in research to probe p38α signaling and related pathways; it also inhibits casein kinase I (CK1δ/ε) and has demonstrated efficacy in preclinical inflammation models.
- Potent p38α inhibition (IC50 7.1 nM) with reduced activity against p38β (IC50 200 nM).
- Reported inhibition of CK1δ/ε and modulation of Wnt/β-catenin signaling.
- Chemical formula C24H21N3OS; molecular weight 399.51 g/mol.
- High reported purity (99.76%).
- Soluble in DMSO (≈50 mg/mL) with suggested protocols for in vivo formulation.
- Powder stable at -20°C for extended storage; solvent stocks stable at -80°C.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.